Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,193 stories, page 507 of 704

Advanced search

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07702968: Low-Field MRI in Stroke Code Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07678970: A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07671092: Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07662798: A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07543692: Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07497503: A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07404202: A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07271186: Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07224113: Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07039539: Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT07005128: A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT06906341: Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT06693687: A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT06498973: Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT06161506: Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT06122220: Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT05915962: Biological Characterization Study of an Autograft Nanofat (Nanocarabio)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT05886049: A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT05331625: Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT05228275: Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT04886180: Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated With Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT04640142: Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT04231851: CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT04188145: A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT04169737: Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT04062266: AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT03693170: Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT03599752: Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT00804154: Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 16Researchclinicaltrials.govTier 1 · Trial registry

NCT00001373: Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech’s Sac-TMT–Keytruda Combination Outperforms Standard First-Line Therapy in Phase III Lung Cancer Trial

BioPharma APACOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Lobbying Update: $90,000 of LEGEND BIOTECH CORPORATION lobbying was just disclosed

Quiver QuantitativeOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

Every baby in England to get life-saving genetic test from birth

All babies in England will be screened for spinal muscular atrophy (SMA).

UK Department of Health and Social CareOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Transforming the pharmaceutical supply chain: a call to action for UK pharmacy

The Pharmaceutical JournalOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Biotech’s historic M&A run rate

biocentury.comOriginal source

🇮🇹Jul 16Industryrecordati.comTier 1 · Company source

Approval of the Issuer’s statement pursuant to art 103 para 3 of Leg Decree no. 58/1998, in connection with the public VTO for all the ordinary shares of Recordati Spa launched by Respighi BidCo Spa

RecordatiOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Biotech: Bill aims to scrutinize US-China ties

Table.BriefingsOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

“Is this Drug Safe?” Why Pharmacists’ Biases Matter for Customers

The People's PharmacyOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

President Lee Jae Myung Orders Mifegyne Review Amid Medical Backlash

조선일보Original source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Funding Gap Between Overall Survival Data and Investor Near-Term Expectations Is Stalling Oncology Drug Development, Says Oncolytics Biotech CEO Jared Kelly

BioPharm InternationalOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

FDA framework for modern preclinical drug development - SelectScience interview

Select ScienceOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

CPC Biotech Introduces One-Inch Flow Path, Single-Use Sterile Disconnect for Bioprocessing

PR NewswireOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Women’s health attracted record equity in 2025 as companies share capital

Pharmaceutical TechnologyOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Tarsus acquires iRenix Medical, adds late-stage ocular antiseptic

Eyes On EyecareOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One

PharmTech.comOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Orca Bio bringing more biotech jobs to Sacramento

KCRAOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

FDA Approves Reytorpyk for Advanced Breast Cancer | PharmExec

Pharmaceutical ExecutiveOriginal source

🇺🇸Jul 16universitynews.mit.eduTier 2 · Direct publisher

MIT Professor Susumu Tonegawa, renowned molecular biologist and Nobel laureate, dies at 86

MIT Biology NewsOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Cannara Biotech (LOVE) Investor presentation Summary

QuartrOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

America must win the biotech competition with China

Washington TimesOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Why VERAXA Biotech (VRXA) Could Benefit More Than Others From AI's Growing Impact on Drug R&D

NewMediaWireOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Cornyn, Tillis Urge Blanche to Protect Life, Counter Dangerous Mail-Order Abortion Drugs

Senator Cornyn (.gov)Original source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Siya Goyal family's spice shop shut over food safety breach

RediffOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

MAXONA PHARMACEUTICALS RECEIVES FDA IND CLEARANCE FOR MAX-001 PHASE 2 ACUTE PAIN CLINICAL TRIAL

BioSpaceOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Proposed legislation aims to lower prescription drug costs, reduce barriers for drug manufacturers

WBNGOriginal source

🌍Jul 16Mediacryopak.comTier 2 · Direct publisher

Plastic Free July in Pharma: A Roadmap to Reusable Cold Chain

CryopakOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

India's Sun Pharma wins South Africa approval to launch generic Ozempic

ReutersOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

FDA drug approval affects health care around the world, but political shortcuts could hurt the agency's reputation

Medical XpressOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Method-of-Use Claims After Teva v. Eli Lilly and In re Xencor: Written Description, Enablement, and the Known-Compound Genus

Foley & Lardner LLPOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development

Applied Clinical Trials OnlineOriginal source